#USA #Cambridge #Zifo #CDISC #TLFGenix

Zifo's TLFGenix Recognized at 2026 CDISC AI Innovation Challenge

In a remarkable showcase of innovation, Zifo, a premier global enabler of AI and data-driven informatics for science-focused organizations, has achieved runner-up status in the 2026 CDISC AI Innovation Challenge. This accolade highlights Zifo's dedication to harnessing AI for clinical reporting through their cutting-edge solution, TLFGenix.

Overview of the Challenge

The CDISC AI Innovation Challenge attracted an impressive 50 submissions from 30 organizations this year. Designed to promote advancements in clinical research data standards, the challenge required participants to leverage AI in generating clinical outputs that are both efficient and compliant. Zifo's TLFGenix was particularly noted for its effectiveness in automating the production of clinical trial tables, figures, and listings (TLFs), ensuring a clear audit trail from the study's objectives to the final outputs.

What is TLFGenix?

TLFGenix is an innovative solution tailored for generating submission-ready clinical trial outputs. It integrates seamlessly with SAP and ADaM datasets, transforming them into traceable tables, figures, and listings with rigorous compliance. The unique end-to-end AI pipeline processes inputs systematically, ensuring that every stage maintains human oversight and approval, which is crucial in regulated environments.

The solution addresses critical steps in statistical analysis and clinical reporting, traditionally a labor-intensive process requiring extensive programming and review. By combining sophisticated AI and adherence to established data standards, TLFGenix represents a significant advancement in the field.

Innovative Features

• - Specialized Workflow: TLFGenix employs six distinct agents to digitize Statistical Analysis Plans (SAP), profile ADaM datasets, generate aligned analysis specifications, produce R driver scripts, and maintain output consistency. Each generated TLF is subjected to thorough checks before finalization.
• - Human Oversight: Unlike many automated systems that exist today, Zifo’s solution balances automation with the indispensable human expertise necessary in clinical settings. Statisticians approve analysis specifications and validate outputs, reinforcing the solution’s credibility and reliability.
• - Efficient Auditable Processes: Zifo's commitment to accuracy is reflected in the lineage graph which connects analysis objectives, endpoints, and results. If any specification changes occur, TLFGenix identifies affected outputs to ensure accurate reapproval processes.
• - Traceability: Each output includes a structured evidence record, ensuring all developments are traceable and compliant with industry standards.

Recognition and Future Prospects

Zifo's recognition at the 2026 CDISC AI Innovation Challenge marks the second consecutive year the company has received this honor, previously being acknowledged in 2025 for its solution addressing unified study definitions and semantic traceability. As the demand for efficient automation in clinical research continues to rise, Zifo’s innovations stand at the forefront of transforming the industry.

In an upcoming showcase at the 2026 CDISC US Interchange in Denver, Zifo will unveil TLFGenix to a broader audience, potentially influencing future patterns in clinical research practices.

Conclusion

Zifo continues to affirm its position as a leader in data-driven clinical informatics. Through TLFGenix, the company exemplifies how AI can enhance clinical workflows while ensuring compliance and maintaining the essential human element in decision-making processes. As the landscape of clinical testing evolves, Zifo’s commitment to innovation and excellence paves the way for enhanced efficiency and integrity in scientific research.